Press Releases Year All Years 2021 2020 2019 2018 2017 2016 2015 2014 Category All Releases Financial Releases Recro Pharma Announces Presentations at PAINWeek 2015 Sep 10, 2015 7:00am EDT Recro Pharma Reports Second Quarter 2015 Financial Results Aug 14, 2015 4:05pm EDT Recro Pharma Announces Additional Information for Phase II Clinical Trial of Dex-IN Jul 24, 2015 7:00am EDT Recro Pharma Appoints Scott Rizzo as General Manager Jul 20, 2015 4:01pm EDT Recro Pharma Announces Positive Top-Line Results for Phase II Clinical Trial of Dex-IN Jul 17, 2015 8:00am EDT Recro Pharma Completes $16 Million Private Financing Jul 07, 2015 5:01pm EDT Recro Pharma Announces $16 Million Financing Jul 01, 2015 9:15am EDT Recro Pharma to Present at the Jefferies 2015 Global Healthcare Conference May 28, 2015 11:00am EDT Recro Pharma Reports First Quarter 2015 Financial Results May 12, 2015 10:03pm EDT Recro Pharma Completes Acquisition of IV/IM Meloxicam and cGMP Manufacturing Facility and Business Unit From Alkermes Apr 13, 2015 11:00am EDT Prev 1... 8 9 10 11 12 13 14 15 16 17 Next
Recro Pharma Announces Additional Information for Phase II Clinical Trial of Dex-IN Jul 24, 2015 7:00am EDT
Recro Pharma Announces Positive Top-Line Results for Phase II Clinical Trial of Dex-IN Jul 17, 2015 8:00am EDT
Recro Pharma Completes Acquisition of IV/IM Meloxicam and cGMP Manufacturing Facility and Business Unit From Alkermes Apr 13, 2015 11:00am EDT
